Skip to main content
OIDA Image Collection
Filters:
Reset 
This is an infographic comparing general perspectives on Abuse-Deterrent Formulations guidances by the US Food and Drug Administration (FDA). The left half shows the perspective of an Innovator and the right half shows the perspective of a Generic. Both share the same beginning (Category 1 = In vitro laboratory testing & Category 2 = PK testing) but Innovator has additional levels (Category 3 = HAP testing & Category 4 = Post-marketing studies).

Title

General perspective on ADF guidances

Description

This is an infographic comparing general perspectives on Abuse-Deterrent Formulations guidances by the US Food and Drug Administration (FDA). The left half shows the perspective of an Innovator and the right half shows the perspective of a Generic. Both share the same beginning (Category 1 = In vitro laboratory testing & Category 2 = PK testing) but Innovator has additional levels (Category 3 = HAP testing & Category 4 = Post-marketing studies).

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"General perspective on ADF guidances." OIDA Image Collection. Available at https://images.oida-resources.jhu.edu/c3462eb5-0a8e-4ccc-bdbd-49b3cb0c30b3